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Abstract 
 
Background: Increased blood glucose and impaired pressure reactivity (PRx) after 
traumatic brain injury (TBI) are both known to correlate with unfavourable patient 
outcome. However the relationship between these two variables is unknown.  
 
Methods: To test the hypothesis that increased blood glucose leads to increased PRx, 
we retrospectively analysed data from 86 traumatic brain injured patients admitted to 
the Neurocritical Care Unit. Data analysed included arterial glucose concentration, 
intracranial pressure (ICP), cerebral perfusion pressure (CPP) and end-tidal CO2. PRx 
was calculated as the moving average between arterial blood pressure and ICP. One 
arterial glucose concentration and one time-aligned PRx value were obtained for each 
patient, during each day until the 5th day after ictus. 
 
Results: Mean arterial glucose concentrations during the first 5 days since ictus were 
positively correlated with mean PRx (Pearson correlation coefficient = 0.25, P = 
0.02). The correlation was strongest on the first day after injury (Pearson correlation 
coefficient = 0.47, P = 0.008). 
 
Conclusion: Our preliminary findings indicate that increased blood glucose may 
impair cerebrovascular reactivity, potentially providing a mechanistic link between 
increased blood glucose and poorer outcome after TBI. 
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Introduction 
Trauma to the brain causes a cascade of metabolic, haemodynamic, and 
cerebrovascular events including impaired brain autoregulation, brain edema, cerebral 
hypoperfusion, hyperaemia, and catecholamine release 1,2. The catecholamine release 
not only supports the cardiovascular system, but also causes an adrenergic increase in 
blood glucose concentration 3.  
 
The increase in blood glucose has been shown to correlate with poorer outcomes 
following head injury 4 leading to a focus on tight glycaemic control protocols 5. 
Thus,  elevated  glucose  has  been  seen  as  a  potentially  modifiable  ‘secondary  insult,’  
much like hypotension, hypoxia, and intracranial hypertension. This is an attractive 
therapeutic target as blood glucose levels can be relatively easily controlled by means 
of an insulin infusion. 
 
However, mechanisms linking elevated blood glucose to poorer outcomes remain 
obscure. It has been postulated that increased glucose leads to a hyperglycolytic state, 
which, if combined with cerebral ischaemia, leads to an increase in cerebral anaerobic 
metabolism 6,7. Whilst another study has indicated that increased blood glucose may 
in fact improve cerebral metabolism 8. An alternative, and as yet unexplored 
mechanism, is that increased blood glucose impairs cerebral autoregulation, therefore 
predisposing to further ischaemic and hyperaemic insults and poor outcome.  
 
Cerebral autoregulation acts to maintain cerebral blood flow across a range of 
perfusion pressures thus protecting the brain from both hyperaemic and ischaemic 
insults 9. A correlate of autoregulation is pressure reactivity (PRx) measured as the 
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correlation between arterial blood pressure (ABP) and intracranial pressure (ICP) 10. 
A negative correlation implies active pressure reactivity whilst a positive correlation 
implies a ‘pressure passive’, impaired pressure reactivity. Like glucose, PRx has been 
shown to independently predict outcome after traumatic brain injury 10. The 
relationship between blood glucose and pressure reactivity has not been investigated.  
 
The aim of this study was to determine if increased blood glucose after traumatic 
brain injury has any relationship on pressure reactivity. We hypothesized that 
hyperglycemia would be associated with impaired pressure reactivity. 
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Methods 
 
Patients and methods 
The data in this study was gathered during a retrospective analysis of data collected 
prospectively from 86 head-injured patients admitted to the Addenbrooke’s   Hospital 
Neurocritical Care Unit between January 2010 and December 2012. Consecutive 
traumatic brain injured patients with a clinical need for intracranial pressure 
monitoring were included for analysis. Informed consent was obtained from all 
patients (or their next of kin) for the use of collected data for research purposes. The 
study was approved by the institutional ethics committee (29 REC 97/291) 
 
Inclusion criteria were: traumatic brain injury as diagnosis on admission; invasive 
monitoring of intracranial pressure and arterial blood pressure; at least 12 hours of 
monitoring with a coincident blood test. Cerebrovascular data in the 2 hours before 
and 2 hours after arterial blood sampling were used.  
 
Patients were managed according to current traumatic brain injury guidelines 2. 
Patients were sedated, intubated, ventilated and paralysed. Interventions were aimed 
at keeping ICP < 20 mm Hg using a stepwise approach of positioning, sedation, 
muscle paralysis, moderate hyperventilation, ventriculostomy, osmotic agents, and 
induced hypothermia. CPP was maintained > 60 - 70 mm Hg using intravenous fluids, 
vasopressors and inotropes. Glucose management was as per insulin sliding insulin 
infusion scale, with target blood glucose levels of between 6 and 8 mmol/L. Glasgow 
outcome scale was assessed at 6 months (1 - death, 2 -persistent vegetative state, 3 - 
severe disability, 4 – moderate disability, 5 – severe disability) 
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 Data acquisition and analyses 
ICP was monitored with an intraparenchymal microsensor inserted into the right 
frontal cortex (Codman ICP MicroSensor, Codman & Shurtleff, Raynham, MA) with 
a zero calibration at the level of the foramen of Munro and arterial blood pressure was 
monitored in the radial or femoral artery with a zero calibration at the level of the 
right atrium (Baxter Healthcare CA, USA; Sidcup, UK). End-tidal CO2 data were 
collected from the ventilator. 
 
Data were sampled at 100 Hz with proprietary data acquisition software (ICM +, 
Cambridge Enterprise, Cambridge, UK) and stored for subsequent analysis. Data were 
collected for each day that simultaneous ICP monitoring and arterial blood sampling 
data were available. PRx was calculated as the Pearson correlation of 30 consecutive 
10-second average values of ABP and ICP. A 10-second average was used to reduce 
the influence of respiratory and pulse waveforms. A 300-second moving window was 
used to generate continuous PRx values. For each day, 4 hours of time-averaged 
cerebrovascular data (CPP, ICP, PRx, end –tidal CO2) were assessed along with one 
time-aligned arterial blood glucose test taken from the radial or femoral arterial line. 
Data were collected only for the first 5 days since ictus.  
 
Statistical Analyses 
Ordinal data are presented as medians with their interquartile range (IQR) and 
continuous data as means and associated standard deviation. Bivariate correlational 
analyses (Pearson coefficient) between glucose, CPP, ICP, end-tidal CO2 and PRx 
were calculated. Correlations are zero-order and unadjusted for multiple comparisons.  
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All data analyses were performed on SPSS version 21.0 software (SPSS Inc., 
Chicago, IL). 
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 Results 
  
Summary details for the 86 patients are shown in table 1. The median age of the 
cohort was 41 with and the median initial GCS was 8. 27% of the patients were 
female. Mortality at 6 months was 22%. Mean physiologic monitoring values during 
the first five days since ictus are shown in table 2. Mean blood glucose was 6.6 mM, 
PRx was 0.02, ICP was 13.1 mm Hg, CPP was 76.4 mm Hg, and PETCO2 was 4.2 
kPa. The sample size increased from 31 one day since ictus to 60 on three days since 
ictus, before falling to 50 on the fifth day since ictus. The varying number of patients 
at different time points represents the varying time taken between ictus and initiation 
of intracranial monitoring, and the varying duration of intracranial monitoring. 
 
Mean arterial glucose concentration for each patient during the first five days from 
ictus was significantly correlated with mean PRx (Pearson correlation 0.25, p = 0.02; 
Table 2 and figure 1). When just those mean arterial glucose concentration values less 
than 8 mmol/L were considered; the correlation between glucose concentration and 
PRx was even stronger (Pearson correlation 0.42, p=0.0001). Similarly, when paired 
glucose concentration and PRx values on the first day from ictus were considered, this 
relationship was stronger (Pearson correlation 0.47, p = 0.008, figure 2).  Pearson 
correlations between arterial glucose concentration on the second and fifth day since 
ictus were also statistically significant. 
 
Correlations of potential confounding variables (ICP, end-tidal CO2, CPP) did not 
approach statistical significance (table 2). 
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Discussion 
The major finding of this study is a weak but significant positive relationship between 
arterial glucose concentration and cerebral pressure reactivity in TBI patients. This 
relationship was strongest when glucose concentration was below 8 mmol/L and 
when the first day since ictus was considered. We propose that hyperglycaemia may 
lead to poor outcome after TBI, at least in part, due to its hitherto undescribed effect 
on cerebral pressure reactivity.  
Two topics warrant further discussion 1) The relation between hyperglycemia and 
impaired vascular function, and 2) impaired vascular function as a potential causal 
link between hyperglycaemia and poor outcome after TBI  
 
Effect of glucose on vascular function 
In the current study we found a significant correlation between arterial concentration 
and PRx in TBI patients (table 2; figure 1), indicating that arterial glucose may impair 
cerebrovascular function.  
Limited data of the effect of glucose on vascular function are available, particularly in 
the cerebral circulation. Some experimental data however indicate a glucose-induced 
impairment of cerebrovascular function. Experimental data from both rats and 
humans have demonstrated that after administration of glucose, regional cerebral 
blood flow is decreased 11,12, while experiments in an isolated pial artery preparation 
observed that elevated glucose concentrations lead to impaired cerebral endothelial 
function 13.  
In addition to impairing the cerebral circulation, elevated glucose concentration has 
been shown to impair vascular function systemically. In non-diabetics, oral glucose 
loading impairs endothelial function as measured with flow mediated dilation in the 
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upper limb 14 and in healthy humans, oral glucose loading impairs brachial artery 
myogenic vasoconstriction. 15. 
Taken together, these experimental data indicate that elevated blood glucose 
concentration impairs endothelial, and smooth muscle cell responses both in the 
cerebral and peripheral vasculature. Clearly, further investigation on the link between 
glucose and pressure reactivity in the TBI population is warranted. 
 
Impaired vascular function as a mediator between hyperglycaemia and outcome after 
TBI 
Although not assessed in the current study due to sample size and frequency, the 
association between elevated glucose and poor outcome after traumatic brain injury is 
well established 4,16,17. However, the physiological significance of this association has 
been debated. Because hyperglycemia is a common finding in many acute conditions 
and is related to the initial GCS 4, it is possible that hyperglycaemia is epiphenomenal 
of a systemic stress response and is a reflection of injury severity. Furthermore, recent 
evidence purports that mild hyperglycaemia may be in fact be beneficial to cerebral 
metabolism 18. 
 
Other evidence, however, indicates that after TBI, hyperglycaemia per se is harmful. 
Hyperglycaemia leads to an increased anaerobic metabolism and acidosis in the brain 
6,19 which in turn can contribute to neuronal dysfunction and brain oedema. Even mild 
increases in arterial blood glucose are associated with cerebral anaerobic metabolism 
as assessed by jugular oximetry20. In addition, elevated brain glucose concentrations 
(greater than 5 mM) have been associated with increased concentration of the 
excitotoxic brain glutamate, a substance known for its excitotoxic properties 21.  
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Our preliminary findings indicate that, in addition to these detrimental metabolic 
effects, hyperglycaemia may impair vascular function. Some support for such a link 
in disease models can be found in the stroke biology literature.  In a rat model, Kawai 
and colleagues demonstrated that a higher blood glucose leads to a greater size of 
infarction 22,23 whilst in humans, diffusion-weighted MRI in post-stroke patients 
revealed that increased blood glucose concentration early in the clinical course is 
associated with an increase in infarction volume 24. Therefore, evidence indicates that 
hyperglycaemia is associated with a greater ischaemic burden, which, combined with 
our data, leads us to speculate that the adverse effects of hyperglycaemia on outcome 
in TBI could be mediated, in part, by impaired cerebrovascular function.  
 
Limitations 
The current study has several important limitations. First, it is possible that the 
observed relationship could be due to the effect of a confounding physiologic variable 
(such as ICP, PRx or end-tidal CO2). However, zero-order correlations of these 
potential confounding factors did not yield any correlations that approached statistical 
significance and justified inclusion in a multivariate model (table 2). The influence of 
other confounders however is still possible. 
Second, glucose concentration data were collected only daily. Because of this low 
density of data points, we limited our analysis to the relationship between glucose 
concentration and PRx between individuals, rather than within individuals. In 
addition, we have only investigated the relationship between glucose concentration 
and pressure reactivity early in the disease course (first five days since ictus). 
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Third, glucose concentration was assessed systemically (arterial blood) rather than 
locally (cerebral microdialysis). Brain tissue glucose concentration could yield 
additional insight into the relationship between glucose and cerebral autoregulation, 
however the focus of this study was to assess the relationship between the prevailing 
glucose concentration presented to the whole brain, rather than the localised 
microdialysis glucose concentration in peri-lesional brain tissue. 
 
Finally, although we speculate that a glucose-mediated impairment of cerebral 
autoregulation may explain in part, worse outcomes in patients with hyperglycaemia, 
we have not assed the effect of glucose on outcome in the current study. Such an 
analysis would likely need a high density of glucose measurements, or glucose 
concentrations very early since ictus.  
 
Conclusion 
We have demonstrated that mild elevation of arterial glucose concentration impairs 
intracranial pressure reactivity, and propose that this effect may be a mechanistic link 
between elevated glucose concentration and poor outcome in TBI. 
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 Figure legends 
 
Figure 1  Correlation between mean arterial glucose and PRx in TBI patients 
during the first 5 days since ictus 
A significant positive relationship between blood glucose and PRx (Pearson 
correlation = 0.25; p = 0.02. Each data point represents the mean of the available 
arterial glucose concentration and PRx measurements during the first 5 days since 
ictus. If only those subjects with mean arterial glucose concentrations below 8 
mmol/L (n=78) are correlated; the relationship is even stronger (Pearson correlation 
0.42; p = 0.0001). 
 
Figure 2  Correlation between arterial glucose concentration and PRx 1 day 
since ictus 
Arterial glucose concentration was positively correlated with PRx (Pearson 
correlation coefficient 0.47; p= 0.008) 
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 1 
Tables  2 
 3 
Table 1: Patient Characteristics (n=86) 4 
 5 
 
Median (IQR) 
Age 41 (34) 
GCS 8 (6) 
6-month GOS 3 (1) 
6-month mortality (%) 22 
Male (%) 73 
Female (%) 27 
 6 
 7 
GCS - Glasgow coma scale; GOS – Glasgow outcome scale (where 1 - death, 2 -8 
persistent vegetative state, 3 - severe disability, 4 – moderate disability, 5 – severe 9 
disability) 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
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Table 2  Mean values (SD) and correlations (unadjusted for multiple comparisons) of physiologic variables during intracranial 28 
monitoring during the first 5 days since ictus 29 
 30 
  
Day 1 
(n=31) 
Day 2  
(n=53) 
Day 3 
(n=61) 
Day 4 
(n=59) 
Day 5 
(n=50) 
 
Day 1-5 
(n=86) 
Arterial glucose  (mmol/L) 6.6 (1.6) 6.5 (1.3) 6.9 (1.6) 6.5 (1.7) 6.8 (1.6) 
 
6.6 (1.1) 
PRx (a.u) 0.06 (0.26) 0.04 (0.28) 0.02 (0.23) 0.01 (0.24) 0.02 (0.21) 
 
0.03 (0.18) 
ICP (mm Hg) 13.9 (6.2) 13.6 (6.5) 13.3 (9.9) 13.1 (6.7) 15 (10.9) 
 
13.1 (5.6) 
CPP (mm Hg) 71.7 (8.5) 75.7 (8.9) 75.9 (15.4) 79.7 (14) 78.9 (15.6) 
 
76.4 (10.9) 
PETCO2 (kPa) 4.2 (0.59) 4.4 (0.7) 4.4 (1.0) 4.4 (0.8) 4.4 (0.65) 
 
4.3 (0.85) 
  
          
 
  
Glucose vs. PRx Pearson coefficient 0.47** 0.27* -0.04 0.22 0.36** 
 
0.25* 
 
p-value 0.008 0.048 0.74 0.09 0.01 
 
0.02 
  
          
 
  
ICP vs. PRx Pearson coefficient 0.11 0.07 0.11 0.14 -0.13 
 
0.09 
 
p-value 0.57 0.64 0.37 0.3 0.37 
 
0.4 
  
          
 
  
CPP vs. PRx Pearson coefficient -0.3 -0.04 -0.16 -0.1 0.12 
 
-0.13 
 
p-value 0.1 0.8 0.2 0.47 0.42 
 
0.25 
  
          
 
  
PETCO2 vs. Prx Pearson coefficient -0.05 -0.23 -0.16 0.04 0.35 
 
-0.01 
 
p-value 0.83 0.2 0.33 0.82 0.07 
 
0.98 
GCS - Glasgow coma scale; GOS – Glasgow outcome scale; ICP – Intracranial pressure; CPP – Cerebral perfusion pressure; PRx - Pressure 31 
reactivity; PETCO2 – Pressure of end-tidal CO2. * P-value less than 0.05, ** P-value less than 0.01.  32 
